Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs GLAND PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES GLAND PHARMA DIVIS LABORATORIES/
GLAND PHARMA
 
P/E (TTM) x 66.3 45.8 144.7% View Chart
P/BV x 7.2 3.8 189.3% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 DIVIS LABORATORIES   GLAND PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
GLAND PHARMA
Mar-23
DIVIS LABORATORIES/
GLAND PHARMA
5-Yr Chart
Click to enlarge
High Rs4,6413,556 130.5%   
Low Rs2,7301,130 241.5%   
Sales per share (Unadj.) Rs292.6214.5 136.4%  
Earnings per share (Unadj.) Rs68.747.5 144.5%  
Cash flow per share (Unadj.) Rs81.656.5 144.5%  
Dividends per share (Unadj.) Rs30.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs480.9484.3 99.3%  
Shares outstanding (eoy) m265.47164.30 161.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.610.9 115.3%   
Avg P/E ratio x53.749.3 108.9%  
P/CF ratio (eoy) x45.241.5 108.8%  
Price / Book Value ratio x7.74.8 158.4%  
Dividend payout %43.70-   
Avg Mkt Cap Rs m978,378385,002 254.1%   
No. of employees `000NANA-   
Total wages/salary Rs m9,7504,033 241.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,67535,245 220.4%  
Other income Rs m3,4472,405 143.3%   
Total revenues Rs m81,12237,650 215.5%   
Gross profit Rs m23,6919,683 244.7%  
Depreciation Rs m3,4321,467 233.9%   
Interest Rs m2074 26.3%   
Profit before tax Rs m23,68610,546 224.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,4532,735 199.3%   
Profit after tax Rs m18,2347,810 233.5%  
Gross profit margin %30.527.5 111.0%  
Effective tax rate %23.025.9 88.7%   
Net profit margin %23.522.2 105.9%  
BALANCE SHEET DATA
Current assets Rs m97,43769,008 141.2%   
Current liabilities Rs m15,3317,291 210.3%   
Net working cap to sales %105.7175.1 60.4%  
Current ratio x6.49.5 67.2%  
Inventory Days Days813 62.7%  
Debtors Days Days84290 933.4%  
Net fixed assets Rs m51,12818,767 272.4%   
Share capital Rs m531165 322.3%   
"Free" reserves Rs m127,14079,406 160.1%   
Net worth Rs m127,67179,571 160.4%   
Long term debt Rs m033 0.0%   
Total assets Rs m148,56587,775 169.3%  
Interest coverage x1,209.5142.6 848.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.4 130.2%   
Return on assets %12.39.0 136.8%  
Return on equity %14.39.8 145.5%  
Return on capital %18.613.3 139.2%  
Exports to sales %85.786.8 98.7%   
Imports to sales %19.80-   
Exports (fob) Rs m66,53730,590 217.5%   
Imports (cif) Rs m15,378NA-   
Fx inflow Rs m66,53730,590 217.5%   
Fx outflow Rs m15,71517,819 88.2%   
Net fx Rs m50,82212,771 398.0%   
CASH FLOW
From Operations Rs m24,5973,640 675.8%  
From Investments Rs m-27,07612,082 -224.1%  
From Financial Activity Rs m-7,972149 -5,343.3%  
Net Cashflow Rs m-10,45115,901 -65.7%  

Share Holding

Indian Promoters % 51.9 0.0 -  
Foreign collaborators % 0.0 57.9 -  
Indian inst/Mut Fund % 36.7 28.2 130.2%  
FIIs % 14.9 4.1 366.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 42.1 114.1%  
Shareholders   354,482 136,021 260.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs GLAND PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs GLAND PHARMA Share Price Performance

Period Divis Laboratories GLAND PHARMA S&P BSE HEALTHCARE
1-Day 2.61% 0.66% 1.18%
1-Month -1.70% 1.81% -0.75%
1-Year 23.07% 45.63% 61.82%
3-Year CAGR -1.23% -9.78% 18.16%
5-Year CAGR 15.87% 0.12% 19.79%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the GLAND PHARMA share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of GLAND PHARMA the stake stands at 57.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of GLAND PHARMA.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

GLAND PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of GLAND PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.